Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

NCT06135103 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: talfirastide
DRUG: Placebo

Sponsor

Constant Therapeutics LLC